Latvia vs Montenegro: Cervical cancer death rate in women
Latvia
7.01 deaths per 100,000 people
in 2023
Montenegro
5.86 deaths per 100,000 people
in 2019
Latvia rank
24th
Montenegro rank
27th
Cervical cancer death rate in women over time
- Latvia
- Montenegro
How they compare
Latvia currently reports 7.01 deaths per 100,000 people against 5.86 deaths per 100,000 people in Montenegro, a difference of 1.15 deaths per 100,000 people.
That makes Latvia's figure about 1.2 times Montenegro's.
Across all 12 years both countries report, Latvia has been ahead every year.
Latvia ranks 24th and Montenegro ranks 27th of 111 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.63 deaths per 100,000 people | 3.43 deaths per 100,000 people | 2.2 deaths per 100,000 people | Latvia |
| 2010s | 6.58 deaths per 100,000 people | 5.06 deaths per 100,000 people | 1.53 deaths per 100,000 people | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cervical cancer death rate in women, Latvia or Montenegro?
- Latvia, at 7.01 deaths per 100,000 people against 5.86 deaths per 100,000 people in Montenegro as of 2023.
- What is the difference in cervical cancer death rate in women between Latvia and Montenegro?
- 1.15 deaths per 100,000 people, with Latvia ahead.
- How many years of comparable data are there for Latvia and Montenegro?
- 12 years are reported by both, from 2000 to 2019.
- How do Latvia and Montenegro rank globally for cervical cancer death rate in women?
- Latvia ranks 24th and Montenegro ranks 27th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Cervical cancer death rate in women. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from cervix uteri cancer in females in those aged all ages per 100,000 people.